Panacos Pharmaceuticals, Inc. Stock: price and insider trades · United States
No insider purchase over the last 90 days. The latest, by Allaway Graham, was filed 18 Dec 2007.
Panacos Pharmaceuticals, Inc.: what insiders have been doing
Panacos Pharmaceuticals, Inc. is a listed company. Its directors and officers file their transactions with SEC (Form 4). Nothing new has been filed by managers of Panacos Pharmaceuticals, Inc. in twelve months, the latest record being from 2 May 2008.
Since 2006, the database holds 23 purchases and 31 sales by insiders of the company.
Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Since the insiders bought
- -86.0%Entry US$0.86 · Close at T+365 US$0.12
- -86.0%Entry US$0.86 · Close at T+365 US$0.12
- -83.1%Entry US$0.83 · Close at T+365 US$0.14
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Financial data
· cache
- 50,000 shares@ US$0.4707Common StockSEC:0001181431-08-028198:0
- 100,000 shares@ US$0.4621Common StockSEC:0001181431-08-028197:0
- 100,000 shares0Common StockSEC:0001181431-08-010685:0
- 75,000 shares0Common StockSEC:0001181431-08-001980:0
- 100,000 shares0Common StockSEC:0001181431-07-076912:0
- 5,000 shares@ US$0.808Common StockSEC:0001181431-07-076080:0Canonical exit: 16 Mar 2008 (T+90)
- 5,000 shares@ US$0.8079Common StockSEC:0001181431-07-076080:1Canonical exit: 16 Mar 2008 (T+90)
- 5,000 shares@ US$0.8075Common StockSEC:0001181431-07-076080:2Canonical exit: 16 Mar 2008 (T+90)
- 10,000 shares@ US$0.82Common StockSEC:0001181431-07-076079:0Canonical exit: 16 Mar 2008 (T+90)
- 3,000 shares@ US$0.83Common StockSEC:0001181431-07-076079:1Canonical exit: 16 Mar 2008 (T+90)
- 5,000 shares@ US$0.84Common StockSEC:0001181431-07-076079:2Canonical exit: 16 Mar 2008 (T+90)
- 2,000 shares@ US$0.87Common StockSEC:0001181431-07-076079:3Canonical exit: 16 Mar 2008 (T+90)
- 10,000 shares@ US$0.88Common StockSEC:0001181431-07-075781:0Canonical exit: 13 Mar 2008 (T+90)
- 20,000 shares@ US$0.88Common StockSEC:0001181431-07-075779:0Canonical exit: 13 Mar 2008 (T+90)
- 13,000 shares@ US$0.8097Common StockSEC:0001181431-07-075779:1Canonical exit: 13 Mar 2008 (T+90)
- 2,000 shares@ US$0.8091Common StockSEC:0001181431-07-075779:2Canonical exit: 13 Mar 2008 (T+90)
- 3,530 shares@ US$0.85Common StockSEC:0001181431-07-075782:0Canonical exit: 13 Mar 2008 (T+90)
- 8,000 shares@ US$0.88Common StockSEC:0001181431-07-075782:1Canonical exit: 13 Mar 2008 (T+90)
- 18,000 shares@ US$0.81Common StockSEC:0001181431-07-075780:0Canonical exit: 13 Mar 2008 (T+90)
- 30,865 shares@ US$0.81Common StockSEC:0001181431-07-075777:0Canonical exit: 13 Mar 2008 (T+90)
- 25,000 shares0Common StockSEC:0001181431-07-066812:0
- 50,000 shares0Common StockSEC:0001181431-07-066817:0
- 50,000 shares0Common StockSEC:0001181431-07-066816:0
- 35,000 shares0Common StockSEC:0001181431-07-066813:0
- 50,000 shares0Common StockSEC:0001181431-07-066815:0
25 of 84 declarations
About Panacos Pharmaceuticals, Inc.
Panacos Pharmaceuticals, Inc. is a company focused on developing antiviral treatments. It is listed on NASDAQ under the ticker symbol PANAC.
